• OPEN AN ACCOUNT
Indian Indices
Sensex
76,917.85 1,225.07
( 1.62%)
Global Indices
Nasdaq
52,165.19 373.88
(0.72%)
Dow Jones
7,596.72 -4.35
(-0.06%)
Hang Seng
63,112.86 -177.25
(-0.28%)
Nikkei 225
10,659.07 -102.26
(-0.95%)
Forex
USD-INR
94.93 -0.28
(-0.30%)
EUR-INR
105.90 -0.29
(-0.27%)
GBP-INR
127.09 0.08
(0.06%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
199.4246723
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
40.97
12176.8
EPS(TTM)
Face Value()
Div & Yield %
28.41
1
0.65
 

ananthis international bakers ltd
Equitas SFB board approves proposal to raise up to Rs 500 crore via private NCD issue
Sep 16,2026

In a regulatory filing made during market hours today, the bank stated that its board has approved the issuance of up to 50,000 rated, listed, unsecured, subordinated, transferable, redeemable, fully paid up, lower tier-II non-convertible debentures, having a face value of Rs 1 lakh each.

These NCDs, which would be categorized as lower tier-II capital, would be issued in dematerialized form on a private placement basis to one or more prospective eligible investors.

Equitas Small Finance Bank is a small finance bank that offers a wide range of products and services tailored to meet the financial needs of its diverse customer base. The bank caters to individuals with limited access to formal financing channels, affluent and mass-affluent customers, Small & Medium Enterprises (SMEs) and corporates.

The small finance bank reported a consolidated net profit of Rs 183.60 crore in Q1 FY27, compared with a net loss of Rs 223.76 crore in Q1 FY26. Total income rose 14.17% year on year to Rs 2,215.49 crore in Q1 FY27.

The scrip rose 0.76% to currently trade at Rs 71.87 on the BSE.